4.4 Article

Why France Spends Less Than the United States on Drugs: A Comparative Study of Drug Pricing and Pricing Regulation

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Changes in List Prices, Net Prices, and Discounts for Branded Drugs in the US, 2007-2018

Inmaculada Hernandez et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Letter Medicine, General & Internal

Decreasing Medicare Spending on Prescription Drugs

Robert Steinbrook

JAMA INTERNAL MEDICINE (2020)

Letter Medicine, General & Internal

Drug Prices, Rebates, and Discounts

Benjamin N. Rome et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Review Medicine, General & Internal

America's Health Care System is Broken: What Went Wrong and How We Can Fix It. Part 4: The Pharmaceutical Industry

Edward P. Hoffer

AMERICAN JOURNAL OF MEDICINE (2019)

Letter Medicine, General & Internal

Price Increases of Protected-Class Drugs in Medicare Part D, Relative to Inflation, 2012-2017

Thomas J. Hwang et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)

Article Medicine, General & Internal

Competition and price among brand-name drugs in the same class: A systematic review of the evidence

Ameet Sarpatwari et al.

PLOS MEDICINE (2019)

Article Health Care Sciences & Services

Price and utilisation differences for statins between four countries

Loc Phuoc Thai et al.

EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2018)

Article Health Care Sciences & Services

Generic Price Competition For Specialty Drugs: Too Little, Too Late?

Ashley L. Cole et al.

HEALTH AFFAIRS (2018)

Review Medicine, General & Internal

Health Care Spending in the United States and Other High-Income Countries

Irene Papanicolas et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)

Article Health Care Sciences & Services

Price comparison of high-cost originator medicines in European countries

Sabine Vogler et al.

EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2017)

Letter Medicine, General & Internal

Prices of Generic Drugs Associated with Numbers of Manufacturers

Chintan V. Dave et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Genetics & Heredity

Determinants of orphan drugs prices in France: a regression analysis

Daria Korchagina et al.

ORPHANET JOURNAL OF RARE DISEASES (2017)

Review Medicine, General & Internal

Association of Prescription Drug Price Rebates inMedicare Part D With Patient Out-of-Pocket and Federal Spending

Stacie B. Dusetzina et al.

JAMA INTERNAL MEDICINE (2017)

Article Health Care Sciences & Services

Prices and distribution margins of in-patent drugs in pharmacy: A comparison in seven European countries

Livio Garattini et al.

HEALTH POLICY (2008)

Article Health Policy & Services

Pharmaceutical regulation in France 1980-2003

V Paris

INTERNATIONAL JOURNAL OF HEALTH PLANNING AND MANAGEMENT (2005)

Article Health Care Sciences & Services

Medication costs, adherence, and health outcomes among Medicare beneficiaries

R Mojtabai et al.

HEALTH AFFAIRS (2003)